These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28934761)

  • 1. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Mendes LST; Balyasnikova S; Evans J; Peckitt C; Begum R; Tait D; Tabernero J; Glimelius B; Roselló S; Thomas J; Oates J; Chau I
    Br J Cancer; 2017 Nov; 117(10):1478-1485. PubMed ID: 28934761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Tumor Regression Grade on MR in Rectal Cancer: A Large-Scale, Single-Center Experience.
    Yoen H; Park HE; Kim SH; Yoon JH; Hur BY; Bae JS; Kim JH; Oh HJ; Han JK
    Korean J Radiol; 2020 Sep; 21(9):1065-1076. PubMed ID: 32691542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of magnetic resonance tumour regression grade in the prediction of regression and survival of rectal adenocarcinoma after long-course chemoradiotherapy: a cohort study.
    Chen HLR; Seow-En I; Chok AY; Ngo NT; Cheng TL; Tan KE
    Ann Med Surg (Lond); 2023 Apr; 85(4):842-848. PubMed ID: 37113901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma.
    Niu S; Chen Y; Peng F; Wen J; Xiong J; Yang Z; Peng J; Bao Y; Ding L
    Front Oncol; 2023; 13():1118518. PubMed ID: 37377906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI tumour regression grade in locally recurrent rectal cancer.
    Voogt ELK; Nordkamp S; van Zoggel DMGI; Daniëls-Gooszen AW; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Cnossen JS; van Lijnschoten G; Burger JWA; Rutten HJT; Nederend J
    BJS Open; 2022 May; 6(3):. PubMed ID: 35552373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modest agreement between magnetic resonance and pathological tumor regression after neoadjuvant therapy for rectal cancer in the real world.
    Achilli P; Magistro C; Abd El Aziz MA; Calini G; Bertoglio CL; Ferrari G; Mari G; Maggioni D; Peros G; Tamburello S; Coppola E; Spinelli A; Grass F; Martin D; Hahnloser D; Salvatori A; De Simoni S; Sheedy SP; Fletcher JG; Larson DW
    Int J Cancer; 2022 Jul; 151(1):120-127. PubMed ID: 35191540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
    Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
    Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
    Yoo GS; Park HC; Yu JI; Choi DH; Cho WK; Park YS; Park JO; Lim HY; Kang WK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Song KD; Kim SH; Ha SY
    Cancer Res Treat; 2020 Apr; 52(2):446-454. PubMed ID: 31588705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
    Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
    AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
    Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
    World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer.
    Suzuki C; Halperin SK; Nilsson PJ; Martling A; Holm T
    Eur J Surg Oncol; 2022 Jul; 48(7):1643-1649. PubMed ID: 35272899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy.
    Jang JK; Choi SH; Park SH; Kim KW; Kim HJ; Lee JS; Kim AY
    Eur Radiol; 2020 Apr; 30(4):2312-2323. PubMed ID: 31953656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG).
    Siddiqui MR; Gormly KL; Bhoday J; Balyansikova S; Battersby NJ; Chand M; Rao S; Tekkis P; Abulafi AM; Brown G
    Clin Radiol; 2016 Sep; 71(9):854-62. PubMed ID: 27381221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.
    Lee YD; Kim HG; Seo M; Moon SK; Park SJ; You MW
    Int J Colorectal Dis; 2024 May; 39(1):78. PubMed ID: 38789861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
    Patel UB; Taylor F; Blomqvist L; George C; Evans H; Tekkis P; Quirke P; Sebag-Montefiore D; Moran B; Heald R; Guthrie A; Bees N; Swift I; Pennert K; Brown G
    J Clin Oncol; 2011 Oct; 29(28):3753-60. PubMed ID: 21876084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study.
    Guan Z; Sun RJ; Cao WT; Zhang HM; Yu T; Yu XP; Zhang JX; Zhang XY; Li XT; Zhou ZY; Zhao XM; Wen L; Sun YS
    Radiother Oncol; 2020 Oct; 151():288-295. PubMed ID: 32890612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
    Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer.
    Jang JK; Lee JL; Park SH; Park HJ; Park IJ; Kim JH; Choi SH; Kim J; Yu CS; Kim JC
    Br J Surg; 2018 Nov; 105(12):1671-1679. PubMed ID: 29893988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.
    Kim H; Myoung S; Koom WS; Kim NK; Kim MJ; Ahn JB; Hur H; Lim JS
    PLoS One; 2016; 11(1):e0146235. PubMed ID: 26730717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical predictors of tumor response after neoadjuvant therapy in rectal cancer.
    Bedrikovetski S; Traeger L; Vather R; Moore JW; Sammour T
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):365-373. PubMed ID: 36305516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.